Mingyang Song1,2,3, Kana Wu3, Jeffrey A Meyerhardt4, Shuji Ogino4,5,6, Molin Wang5,7, Charles S Fuchs8,9,10, Edward L Giovannucci3,5,11, Andrew T Chan1,2,11,12. 1. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston. 2. Division of Gastroenterology, Massachusetts General Hospital, Boston. 3. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 4. Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. 5. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 6. Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 7. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 8. Yale Cancer Center, New Haven, Connecticut. 9. Department of Medicine, Yale School of Medicine, New Haven, Connecticut. 10. Department of Medical Oncology, Smilow Cancer Hospital, New Haven, Connecticut. 11. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 12. Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.
Abstract
IMPORTANCE: Although high dietary fiber intake has been associated with a lower risk of colorectal cancer (CRC), it remains unknown whether fiber benefits CRC survivors. OBJECTIVE: To assess the association of postdiagnostic fiber intake with mortality. DESIGN, SETTING, AND PARTICIPANTS: A total of 1575 health care professionals with stage I to III CRC were evaluated in 2 prospective cohorts, Nurses' Health Study and Health Professionals Follow-up Study. Colorectal cancer-specific and overall mortality were determined after adjusting for other potential predictors for cancer survival. The study was conducted from December 23, 2016, to August 23, 2017. EXPOSURES: Consumption of total fiber and different sources of fiber and whole grains assessed by a validated food frequency questionnaire between 6 months and 4 years after CRC diagnosis. MAIN OUTCOMES AND MEASURES: Hazard ratios (HRs) and 95% CIs of CRC-specific and overall mortality after adjusting for other potential predictors for cancer survival. RESULTS: Of the 1575 participants, 963 (61.1%) were women; mean (SD) age was 68.6 (8.9) years. During a median of 8 years of follow-up, 773 deaths were documented, including 174 from CRC. High intake of total fiber after diagnosis was associated with lower mortality. The multivariable HR per each 5-g increment in intake per day was 0.78 (95% CI, 0.65-0.93; P = .006) for CRC-specific mortality and 0.86 (95% CI, 0.79-0.93; P < .001) for all-cause mortality. Patients who increased their fiber intake after diagnosis from levels before diagnosis had a lower mortality, and each 5-g/d increase in intake was associated with 18% lower CRC-specific mortality (95% CI, 7%-28%; P = .002) and 14% lower all-cause mortality (95% CI, 8%-19%; P < .001). According to the source of fiber, cereal fiber was associated with lower CRC-specific mortality (HR per 5-g/d increment, 0.67; 95% CI, 0.50-0.90; P = .007) and all-cause mortality (HR, 0.78; 95% CI, 0.68-0.90; P < .001); vegetable fiber was associated with lower all-cause mortality (HR, 0.83; 95% CI, 0.72-0.96; P = .009) but not CRC-specific mortality (HR, 0.82; 95% CI, 0.60-1.13; P = .22); no association was found for fruit fiber. Whole grain intake was associated with lower CRC-specific mortality (HR per 20-g/d increment, 0.72; 95% CI, 0.59-0.88; P = .002), and this beneficial association was attenuated after adjusting for fiber intake (HR, 0.77; 95% CI, 0.62-0.96; P = .02). CONCLUSIONS AND RELEVANCE: Higher fiber intake after the diagnosis of nonmetastatic CRC is associated with lower CRC-specific and overall mortality. Increasing fiber consumption after diagnosis may confer additional benefits to patients with CRC.
IMPORTANCE: Although high dietary fiber intake has been associated with a lower risk of colorectal cancer (CRC), it remains unknown whether fiber benefits CRC survivors. OBJECTIVE: To assess the association of postdiagnostic fiber intake with mortality. DESIGN, SETTING, AND PARTICIPANTS: A total of 1575 health care professionals with stage I to III CRC were evaluated in 2 prospective cohorts, Nurses' Health Study and Health Professionals Follow-up Study. Colorectal cancer-specific and overall mortality were determined after adjusting for other potential predictors for cancer survival. The study was conducted from December 23, 2016, to August 23, 2017. EXPOSURES: Consumption of total fiber and different sources of fiber and whole grains assessed by a validated food frequency questionnaire between 6 months and 4 years after CRC diagnosis. MAIN OUTCOMES AND MEASURES: Hazard ratios (HRs) and 95% CIs of CRC-specific and overall mortality after adjusting for other potential predictors for cancer survival. RESULTS: Of the 1575 participants, 963 (61.1%) were women; mean (SD) age was 68.6 (8.9) years. During a median of 8 years of follow-up, 773 deaths were documented, including 174 from CRC. High intake of total fiber after diagnosis was associated with lower mortality. The multivariable HR per each 5-g increment in intake per day was 0.78 (95% CI, 0.65-0.93; P = .006) for CRC-specific mortality and 0.86 (95% CI, 0.79-0.93; P < .001) for all-cause mortality. Patients who increased their fiber intake after diagnosis from levels before diagnosis had a lower mortality, and each 5-g/d increase in intake was associated with 18% lower CRC-specific mortality (95% CI, 7%-28%; P = .002) and 14% lower all-cause mortality (95% CI, 8%-19%; P < .001). According to the source of fiber, cereal fiber was associated with lower CRC-specific mortality (HR per 5-g/d increment, 0.67; 95% CI, 0.50-0.90; P = .007) and all-cause mortality (HR, 0.78; 95% CI, 0.68-0.90; P < .001); vegetable fiber was associated with lower all-cause mortality (HR, 0.83; 95% CI, 0.72-0.96; P = .009) but not CRC-specific mortality (HR, 0.82; 95% CI, 0.60-1.13; P = .22); no association was found for fruit fiber. Whole grain intake was associated with lower CRC-specific mortality (HR per 20-g/d increment, 0.72; 95% CI, 0.59-0.88; P = .002), and this beneficial association was attenuated after adjusting for fiber intake (HR, 0.77; 95% CI, 0.62-0.96; P = .02). CONCLUSIONS AND RELEVANCE: Higher fiber intake after the diagnosis of nonmetastatic CRC is associated with lower CRC-specific and overall mortality. Increasing fiber consumption after diagnosis may confer additional benefits to patients with CRC.
Authors: Mingyang Song; Xuehong Zhang; Jeffrey A Meyerhardt; Edward L Giovannucci; Shuji Ogino; Charles S Fuchs; Andrew T Chan Journal: Gut Date: 2016-07-19 Impact factor: 23.059
Authors: Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler Journal: CA Cancer J Clin Date: 2012-04-26 Impact factor: 508.702
Authors: R A Bras-Gonçalves; M Pocard; J L Formento; F Poirson-Bichat; G De Pinieux; I Pandrea; F Arvelo; G Ronco; P Villa; A Coquelle; G Milano; T Lesuffleur; B Dutrillaux; M F Poupon Journal: Gastroenterology Date: 2001-03 Impact factor: 22.682
Authors: Hongyu Wu; Alan J Flint; Qibin Qi; Rob M van Dam; Laura A Sampson; Eric B Rimm; Michelle D Holmes; Walter C Willett; Frank B Hu; Qi Sun Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: Brian M Wolpin; Jeffrey A Meyerhardt; Andrew T Chan; Kimmie Ng; Jennifer A Chan; Kana Wu; Michael N Pollak; Edward L Giovannucci; Charles S Fuchs Journal: J Clin Oncol Date: 2008-12-08 Impact factor: 44.544
Authors: Chelsia Gillis; Chao Li; Lawrence Lee; Rashami Awasthi; Berson Augustin; Ann Gamsa; A Sender Liberman; Barry Stein; Patrick Charlebois; Liane S Feldman; Francesco Carli Journal: Anesthesiology Date: 2014-11 Impact factor: 7.892
Authors: Nicholas Arpaia; Clarissa Campbell; Xiying Fan; Stanislav Dikiy; Joris van der Veeken; Paul deRoos; Hui Liu; Justin R Cross; Klaus Pfeffer; Paul J Coffer; Alexander Y Rudensky Journal: Nature Date: 2013-11-13 Impact factor: 49.962
Authors: Meghan B Skiba; Lindsay N Kohler; Tracy E Crane; Elizabeth T Jacobs; Aladdin H Shadyab; Ikuko Kato; Linda Snetselaar; Lihong Qi; Cynthia A Thomson Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-08-27 Impact factor: 4.254
Authors: Wanshui Yang; Yanan Ma; Stephanie Smith-Warner; Mingyang Song; Kana Wu; Molin Wang; Andrew T Chan; Shuji Ogino; Charles S Fuchs; Vitaliy Poylin; Kimmie Ng; Jeffrey A Meyerhardt; Edward L Giovannucci; Xuehong Zhang Journal: Clin Cancer Res Date: 2018-12-13 Impact factor: 12.531
Authors: Erin L Van Blarigan; Fang-Shu Ou; Donna Niedzwiecki; Sui Zhang; Charles S Fuchs; Leonard Saltz; Robert J Mayer; Alan Venook; Shuji Ogino; Mingyang Song; Al Benson; Alexander Hantel; James N Atkins; Edward L Giovannucci; Jeffrey A Meyerhardt Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-07-23 Impact factor: 4.254
Authors: Alfredo Erazo-Oliveras; Natividad R Fuentes; Rachel C Wright; Robert S Chapkin Journal: Cancer Metastasis Rev Date: 2018-09 Impact factor: 9.264
Authors: Wanshui Yang; Edward L Giovannucci; Susan E Hankinson; Andrew T Chan; Yanan Ma; Kana Wu; Charles S Fuchs; I-Min Lee; Howard D Sesso; Jennifer H Lin; Xuehong Zhang Journal: Int J Cancer Date: 2020-01-11 Impact factor: 7.396
Authors: Moniek van Zutphen; Fränzel J B van Duijnhoven; Evertine Wesselink; Ruud W M Schrauwen; Ewout A Kouwenhoven; Henk K van Halteren; Johannes H W de Wilt; Renate M Winkels; Dieuwertje E Kok; Hendriek C Boshuizen Journal: Cancers (Basel) Date: 2021-05-18 Impact factor: 6.639